T79K (p.Thr79Lys) variant of TTR (Transthyretin)
T79K (p.Thr79Lys) in TTR (Transthyretin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Cardiovascular phenotype; not provided; Amyloidosis, hereditary systemic 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes published literature and structural context.
T79K (p.Thr79Lys) variant details
- p.Thr79Lys
- rs730881163
- ClinGen CA297521
- NCI-TCGA Cosmic COSV5270
- NCI-TCGA Cosmic COSV9937
- Pathogenic/Likely pathogenic
- Cardiovascular phenotype; not provided; Amyloidosis, hereditary systemic 1
- Missense
- Variant Prioritization Score for Impact Estimate 0.736
- AlphaMissense 0.54
- MetaLR 0.92
- MetaSVM 1.01
- PolyPhen-2 1.00
- SIFT 0.05
- EVE 0.30
- ClinVar: Pathogenic/Likely pathogenic (Cardiovascular phenotype; not provided; Amyloidosis, hereditary)
- EBI: Pathogenic (in AMYLD1)
- UniProt: Pathogenic (in AMYLD1)
- Structural context available
- Cited in: A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian… (PMID 7850982)
- Cited in: Hereditary Transthyretin Amyloidosis. (PMID 20301373)